{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T17:10:08Z","timestamp":1712423408951},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s12328-011-0221-1","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T04:58:51Z","timestamp":1305003531000},"page":"179-183","source":"Crossref","is-referenced-by-count":0,"title":["Acute septic shock during pegylated-interferon and ribavirin therapy in a patient with chronic hepatitis C who underwent aortic graft replacement"],"prefix":"10.1007","volume":"4","author":[{"given":"Yoshinao","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohta","family":"Nishihama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiro","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohoh","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Fukutome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"221_CR1","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958\u201365.","journal-title":"Lancet"},{"key":"221_CR2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2036.2010.04269.x","volume":"31","author":"R Mac Nicholas","year":"2010","unstructured":"Mac Nicholas R, Norris S. Optimizing SVR and management of the haematological side effects of peginterferon\/ribavirin antiviral therapy for HCV\u2014the role of epoetin, G-CSF and novel agents. Aliment Pharmacol Ther. 2010;31:929\u201337.","journal-title":"Aliment Pharmacol Ther"},{"key":"221_CR3","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1046\/j.1365-2036.2002.01331.x","volume":"16","author":"GB Gaeta","year":"2002","unstructured":"Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, et al. Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in \u2018real world\u2019 patients with chronic hepatitis C. Aliment Pharmacol Ther. 2002;16:1633\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"221_CR4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/hep.21409","volume":"44","author":"RA Del Rio","year":"2006","unstructured":"Del Rio RA, Post AB, Singer ME. Cost-effectiveness of hematologic growth factors for anemia occurring during hepatitis C combination therapy. Hepatology. 2006;44:1598\u2013606.","journal-title":"Hepatology"},{"key":"221_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1086\/376971","volume":"37","author":"DT Dieterich","year":"2003","unstructured":"Dieterich DT, Spivak JL. Hematologic disorders associated with hepatitis C virus infection and their management. Clin Infect Dis. 2003;37:533\u201341.","journal-title":"Clin Infect Dis"},{"key":"221_CR6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gon\u00e7ales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975\u201382.","journal-title":"N Engl J Med"},{"key":"221_CR7","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0016-5085(03)00394-9","volume":"124","author":"MW Russo","year":"2003","unstructured":"Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology. 2003;124:1711\u20139.","journal-title":"Gastroenterology"},{"key":"221_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1053\/jhep.2002.36502","volume":"36","author":"A Soza","year":"2002","unstructured":"Soza A, Everhart JE, Ghany MG, Doo E, Heller T, Promrat K, Park Y, et al. Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology. 2002;36:1273\u20139.","journal-title":"Hepatology"},{"key":"221_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1358\/mf.2005.27.5.908646","volume":"27","author":"A Juarez-Navarro","year":"2005","unstructured":"Juarez-Navarro A, Vera-de-Le\u00f3n L, Navarro JM, Chirino-Sprung R, D\u00edaz-Hernandez M, Casillas-Davila L, et al. Incidence and severity of infections according to the development of neutropenia during combined therapy with pegylated interferon-alpha2a plus ribavirin in chronic hepatitis C infection. Methods Find Exp Clin Pharmacol. 2005;27:317\u201322.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"221_CR10","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/archinte.162.11.1311","volume":"162","author":"J Palmblad","year":"2002","unstructured":"Palmblad J, Andr\u00e8s E, Maloisel F. Drug-induced neutropenias: all are not alike. Arch Intern Med. 2002;162:1311\u20132.","journal-title":"Arch Intern Med"},{"key":"221_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1365-2893.2007.00870.x","volume":"14","author":"J Koirala","year":"2007","unstructured":"Koirala J, Gandotra SD, Rao S, Sangwan G, Mushtaq A, Htwe TH, et al. Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy. J Viral Hepat. 2007;14:782\u20137.","journal-title":"J Viral Hepat"},{"key":"221_CR12","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/j.1440-1746.2004.03459.x","volume":"19","author":"H Nomura","year":"2004","unstructured":"Nomura H, Tanimoto H, Kajiwara E, Shimono J, Maruyama T, Yamashita N, et al. Factors contributing to ribavirin-induced anemia. J Gastroenterol Hepatol. 2004;19:1312\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"221_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","volume":"140","author":"SJ Hadziyannis","year":"2004","unstructured":"Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004;140:346\u201355.","journal-title":"Ann Intern Med"},{"key":"221_CR14","unstructured":"Oho A, Yoshimoto T, Malamuta M. Kanzo. 2008;49:A492 (in Japanese without English abstract)."},{"key":"221_CR15","first-page":"A413","volume":"106","author":"S Hamaguchi","year":"2009","unstructured":"Hamaguchi S, Tomeno W, Ogawa Y, Kato S, Komeda K, Endo H, et al. Nippon Shokakibyo Gakkai Zasshi. 2009;106:A413 (in Japanese without English abstract).","journal-title":"Nippon Shokakibyo Gakkai Zasshi"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-011-0221-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-011-0221-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-011-0221-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-011-0221-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T16:48:01Z","timestamp":1712422081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-011-0221-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1007\/s12328-011-0221-1","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}